New Diagnostic Tests Could Change Leukemia Prevention And Treatment
A Montana based molecular diagnostic company, Alercell Inc., is pioneering novel techniques to augment the way leukemia is diagnosed, treated and ultimately prevented.
Stay updated with breaking news from Frederic Scheer. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A Montana based molecular diagnostic company, Alercell Inc., is pioneering novel techniques to augment the way leukemia is diagnosed, treated and ultimately prevented.
/PRNewswire/ -- ALERCELL, INC. announced today that it has introduced a molecular Leukemia diagnostic platform. LENA Molecular Dx Leukemia Platform is a core...
/PRNewswire/ -- Alercell today announced the opening of Alercell UK LTD. with principal office in central London (UK). Alercell will develop in London its R&D...
/PRNewswire/ -- ALERCELL, INC. announced today that it has launched a new website LENA DIAGNOSTICS ©" www.lenadx.com. The new site is dedicated only to...
/PRNewswire/ -- ALERCELL, INC. announced today that it has introduced a new Research Use Only (RUO) LENA Q51® Leukemia diagnostic test for commercial sale....